Coxiella burnetii Sterol-Modifying Protein Stmp1 Regulates Cholesterol in the Intracellular Niche

Coxiella burnetii is the causative agent of human Q fever, an emerging infectious disease and significant cause of culture-negative endocarditis. Acute infections are often undiagnosed, there are no licensed vaccines in the United States, and chronic Q fever requires a prolonged antibiotic treatment. ABSTRACT Coxiella burnetii replicates in a phagolysosome-like vacuole called the Coxiella-containing vacuole (CCV). While host cholesterol readily traffics to the CCV, cholesterol accumulation leads to CCV acidification and bacterial death. Thus, bacterial regulation of CCV cholesterol content is essential for Coxiella pathogenesis. Coxiella expresses a sterol-modifying protein, Stmp1, that may function to lower CCV cholesterol through enzymatic modification. Using an Stmp1 knockout (Δstmp1), we determined that Stmp1 is not essential for axenic growth. Inside host cells, however, Δstmp1 mutant bacteria form smaller CCVs which accumulate cholesterol, preferentially fuse with lysosomes, and become more acidic, correlating with a significant growth defect. However, in cholesterol-free cells, Δstmp1 mutant bacteria grow similarly to wild-type bacteria but are hypersensitive to cholesterol supplementation. To better understand the underlying mechanism behind the Δstmp1 mutant phenotype, we performed sterol profiling. Surprisingly, we found that Δstmp1 mutant-infected macrophages accumulated the potent cholesterol homeostasis regulator 25-hydroxycholesterol (25-HC). We next determined whether dysregulated 25-HC alters Coxiella infection by treating wild-type Coxiella-infected cells with 25-HC. Similar to the Δstmp1 mutant phenotype, 25-HC increased CCV proteolytic activity and inhibited bacterial growth. Collectively, these data indicate that Stmp1 alters host cholesterol metabolism and is essential to establish a mature CCV which supports Coxiella growth. IMPORTANCE Coxiella burnetii is the causative agent of human Q fever, an emerging infectious disease and significant cause of culture-negative endocarditis. Acute infections are often undiagnosed, there are no licensed vaccines in the United States, and chronic Q fever requires a prolonged antibiotic treatment. Therefore, new treatment and preventive options are critically needed. Coxiella is an obligate intracellular bacterium that replicates within a large acidic phagolysosome-like compartment, the Coxiella-containing vacuole (CCV). We previously discovered that cholesterol accumulation in the CCV increases its acidification, leading to bacterial death. Therefore, in order to survive in this harsh environment, Coxiella likely regulates CCV cholesterol levels. Here, we found that Coxiella sterol modifying protein (Stmp1) facilitates bacterial growth by reducing CCV cholesterol and host cell 25-hydroxycholesterol (25-HC) levels, which prevents excessive CCV fusion with host lysosomes and CCV acidification. This study establishes that Stmp1-mediated regulation of host cholesterol homeostasis is essential for Coxiella intracellular survival.

[1]  G. Cheng,et al.  25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor , 2020, Cell Research.

[2]  J. Samuel,et al.  Modulation of innate immune signaling by a Coxiella burnetii eukaryotic-like effector protein , 2020, Proceedings of the National Academy of Sciences.

[3]  J. McDonald,et al.  Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol , 2020, Nature Microbiology.

[4]  M. McConville,et al.  EirA Is a Novel Protein Essential for Intracellular Replication of Coxiella burnetii , 2020, Infection and Immunity.

[5]  S. Gilk,et al.  Coxiella burnetii Type 4B Secretion System-dependent manipulation of endolysosomal maturation is required for bacterial growth , 2019, bioRxiv.

[6]  W. Berón,et al.  The role of microtubules and the dynein/dynactin motor complex of host cells in the biogenesis of the Coxiella burnetii-containing vacuole , 2019, PloS one.

[7]  Y. Liu,et al.  Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol , 2018, Journal of Lipid Research.

[8]  T. Tran,et al.  Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages , 2018, Infection and Immunity.

[9]  S. Gilk,et al.  Measuring pH of the Coxiella burnetii Parasitophorous Vacuole , 2017, Current protocols in microbiology.

[10]  S. Winfree,et al.  Quantitative Dextran Trafficking to the Coxiella burnetii Parasitophorous Vacuole , 2017, Current protocols in microbiology.

[11]  Anders Omsland,et al.  Physicochemical and Nutritional Requirements for Axenic Replication Suggest Physiological Basis for Coxiella burnetii Niche Restriction , 2017, Front. Cell. Infect. Microbiol..

[12]  Minal Mulye,et al.  Manipulation of Host Cholesterol by Obligate Intracellular Bacteria , 2017, Front. Cell. Infect. Microbiol..

[13]  Minal Mulye,et al.  Altering lipid droplet homeostasis affects Coxiella burnetii intracellular growth , 2017, bioRxiv.

[14]  R. Heinzen,et al.  Elevated Cholesterol in the Coxiella burnetii Intracellular Niche Is Bacteriolytic , 2017, mBio.

[15]  R. Heinzen,et al.  Interactions between the Coxiella burnetii parasitophorous vacuole and the endoplasmic reticulum involve the host protein ORP1L , 2017, Cellular microbiology.

[16]  D. Muriaux,et al.  Coxiella burnetii effector CvpB modulates phosphoinositide metabolism for optimal vacuole development , 2016, Proceedings of the National Academy of Sciences.

[17]  J. Benach,et al.  Hijacking and Use of Host Lipids by Intracellular Pathogens. , 2015, Microbiology spectrum.

[18]  Sean P. Riley,et al.  Host-Directed Antimicrobial Drugs with Broad-Spectrum Efficacy against Intracellular Bacterial Pathogens , 2014, mBio.

[19]  E. Crabill,et al.  A Screen of Coxiella burnetii Mutants Reveals Important Roles for Dot/Icm Effectors and Host Autophagy in Vacuole Biogenesis , 2014, PLoS pathogens.

[20]  R. Heinzen,et al.  Coxiella burnetii effector protein subverts clathrin-mediated vesicular trafficking for pathogen vacuole biogenesis , 2013, Proceedings of the National Academy of Sciences.

[21]  R. Heinzen,et al.  Sec-mediated secretion by Coxiella burnetii , 2013, BMC Microbiology.

[22]  J. Samuel,et al.  Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii , 2013, Nature Reviews Microbiology.

[23]  D. Kratky,et al.  25-Hydroxycholesterol regulates cholesterol homeostasis in the murine CATH.a neuronal cell line , 2013, Neuroscience Letters.

[24]  G. Cheng,et al.  Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. , 2013, Immunity.

[25]  R. Heinzen,et al.  Bacterial Colonization of Host Cells in the Absence of Cholesterol , 2013, PLoS pathogens.

[26]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[27]  R. Heinzen,et al.  Two Systems for Targeted Gene Deletion in Coxiella burnetii , 2012, Applied and Environmental Microbiology.

[28]  R. Raghavan,et al.  Developmental biology of Coxiella burnetii. , 2012, Advances in experimental medicine and biology.

[29]  P. Beare Genetic manipulation of Coxiella burnetii. , 2012, Advances in experimental medicine and biology.

[30]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[31]  R. Heinzen,et al.  Dot/Icm Type IVB Secretion System Requirements for Coxiella burnetii Growth in Human Macrophages , 2011, mBio.

[32]  D. St Johnston,et al.  Supplementary Figure 5 , 2009 .

[33]  R. Heinzen,et al.  Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium , 2011, Applied and Environmental Microbiology.

[34]  R. Heinzen,et al.  The Coxiella burnetii Cryptic Plasmid Is Enriched in Genes Encoding Type IV Secretion System Substrates , 2011, Journal of bacteriology.

[35]  R. Heinzen,et al.  Coxiella burnetii Expresses a Functional Δ24 Sterol Reductase , 2010, Journal of bacteriology.

[36]  P. Ayoubi,et al.  Coxiella burnetii Nine Mile II proteins modulate gene expression of monocytic host cells during infection , 2010, BMC Microbiology.

[37]  Kyla M. Frohlich,et al.  Rickettsia prowazekii Uses an sn-Glycerol-3-Phosphate Dehydrogenase and a Novel Dihydroxyacetone Phosphate Transport System To Supply Triose Phosphate for Phospholipid Biosynthesis , 2010, Journal of bacteriology.

[38]  R. Heinzen,et al.  Coxiella burnetii Phase I and II Variants Replicate with Similar Kinetics in Degradative Phagolysosome-Like Compartments of Human Macrophages , 2010, Infection and Immunity.

[39]  I. Starakis,et al.  Q fever endocarditis. , 2010, Infectious disorders drug targets.

[40]  D. Raoult,et al.  Evidence that the intra-amoebal Legionella drancourtii acquired a sterol reductase gene from eukaryotes , 2009, BMC Research Notes.

[41]  Y. Rikihisa,et al.  Cholesterol-Dependent Anaplasma phagocytophilum Exploits the Low-Density Lipoprotein Uptake Pathway , 2009, PLoS pathogens.

[42]  Kelly P. Williams,et al.  Comparative Genomics Reveal Extensive Transposon-Mediated Genomic Plasticity and Diversity among Potential Effector Proteins within the Genus Coxiella , 2008, Infection and Immunity.

[43]  M. Colombo,et al.  The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell , 2007, Cellular microbiology.

[44]  R. Heinzen,et al.  Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii , 2007, Cellular microbiology.

[45]  J. Friedman,et al.  Identification of the core transmembrane complex of the Legionella Dot/Icm type IV secretion system , 2006, Molecular microbiology.

[46]  R. Heinzen,et al.  Coxiella burnetii inhabits a cholesterol‐rich vacuole and influences cellular cholesterol metabolism , 2006, Cellular microbiology.

[47]  Joseph L. Goldstein,et al.  Protein Sensors for Membrane Sterols , 2006, Cell.

[48]  Christopher M. Adams,et al.  Cholesterol and 25-Hydroxycholesterol Inhibit Activation of SREBPs by Different Mechanisms, Both Involving SCAP and Insigs* , 2004, Journal of Biological Chemistry.

[49]  M. Zuckermann,et al.  What's so special about cholesterol? , 2004, Lipids.

[50]  R. Heinzen,et al.  Maturation of the Coxiella burnetii parasitophorous vacuole requires bacterial protein synthesis but not replication , 2003, Cellular microbiology.

[51]  R. Heinzen,et al.  Comparative DNA Microarray Analysis of Host Cell Transcriptional Responses to Infection by Coxiella burnetii or Chlamydia trachomatis , 2003, Annals of the New York Academy of Sciences.

[52]  C. Fraser,et al.  Complete genome sequence of the Q-fever pathogen Coxiella burnetii , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Colombo,et al.  Coxiella burnetii Localizes in a Rab7-Labeled Compartment with Autophagic Characteristics , 2002, Infection and Immunity.

[54]  K. Haldar,et al.  The Salmonella‐containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI‐anchored protein CD55 , 2002, Cellular microbiology.

[55]  D. Raoult,et al.  Subversion of monocyte functions by coxiella burnetii: impairment of the cross-talk between alphavbeta3 integrin and CR3. , 1999, Journal of immunology.

[56]  D. Russell,et al.  cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid Metabolism* , 1998, The Journal of Biological Chemistry.

[57]  C. V. van Noorden,et al.  Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes. , 1997, Analytical biochemistry.

[58]  R. Heinzen,et al.  Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis , 1996, Infection and immunity.

[59]  B. Marmion,et al.  Vaccine prophylaxis of Q fever: A follow‐up study of the efficacy of Q‐Vax (CSL) 1985‐1990 , 1994, The Medical journal of Australia.

[60]  F Nistal de Paz,et al.  [Q fever]. , 1994, Medicina clinica.

[61]  N. Grist,et al.  Q fever endocarditis , 1967 .